A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/26/1997	EP0808831A2 Fluorinated vitamin D3 analogs
11/26/1997	EP0808629A1 Sucralfate preparation
11/26/1997	EP0808628A2 Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof
11/26/1997	EP0808627A2 Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof
11/26/1997	EP0808626A1 Use of acetyl-L-carnitine for the treatment of presenile Alzheimer's disease
11/26/1997	EP0808325A1 Androstane and pregnane series for allosteric modulation of gaba receptor
11/26/1997	EP0808324A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
11/26/1997	EP0808322A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF
11/26/1997	EP0808321A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
11/26/1997	EP0808319A1 Epipodophyllotoxin triaryloxyacetyl derivatives, method for preparing same, and use of said derivatives as cancer drugs
11/26/1997	EP0808318A1 Tricyclic substituted hexahydrobenz e]isoindole alpha-1 adrenergic antagonists
11/26/1997	EP0808317A1 Thienopyrimidine derivatives, their production and use
11/26/1997	EP0808316A1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
11/26/1997	EP0808315A1 Carbapenem-3-carboxylic acid ester derivatives
11/26/1997	EP0808314A1 New forms of paroxetin hydrochloride
11/26/1997	EP0808313A1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
11/26/1997	EP0808312A1 Indole derivatives as 5-ht receptor antagonist
11/26/1997	EP0808311A2 New derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds
11/26/1997	EP0808309A1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
11/26/1997	EP0808307A1 Bicyclic isothiourea derivatives useful in therapy
11/26/1997	EP0808306A1 New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds
11/26/1997	EP0808303A1 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist
11/26/1997	EP0808174A1 Medicament in particle form
11/26/1997	EP0808172A2 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
11/26/1997	EP0808171A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
11/26/1997	EP0808168A1 Pharmaceutical composition for the treatment of herpes
11/26/1997	EP0808166A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
11/26/1997	EP0808165A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
11/26/1997	EP0808164A1 Method for treatment of obesity using prolactin modulators and diet
11/26/1997	EP0808163A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
11/26/1997	EP0808162A2 Use of carbazole compounds for the treatment of congestive heart failure
11/26/1997	EP0808161A1 Solid substances comprising valproic acid and sodium valproate
11/26/1997	EP0808160A1 Deprenyl compounds for treatment of glaucoma
11/26/1997	EP0808159A1 USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a)
11/26/1997	EP0808157A1 Medicated tissue paper product
11/26/1997	EP0808156A1 Compositions comprising nanoparticles of nsaid
11/26/1997	EP0808111A1 A LOW PHOSPHORUS ANIMAL FEED CONTAINING 1$g(a)-HYDROXYLATED VITAMIN D COMPOUNDS
11/26/1997	EP0808104A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS
11/26/1997	EP0808103A1 Protein hydroxylation inhibitors for fibroproliferative disorders
11/26/1997	EP0755451A4 Materials and methods for management of hyperacute rejection in human xenotransplantation
11/26/1997	EP0719276B1 Orally active derivatives of 1,3,5(10)-estratriene
11/26/1997	EP0719271B1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
11/26/1997	EP0700398B1 Psoralen derivatives, their preparation and use as medicaments
11/26/1997	EP0691977B1 Oligonucleotides with amide linkages replacing phosphodiester linkages
11/26/1997	EP0686037A4 Hormone replacement therapy
11/26/1997	EP0643712B1 Spiro-oxetanes, process for preparing the same and medicaments
11/26/1997	EP0466816B1 Method for enhancing transmembrane transport of exogenous molecules
11/26/1997	CN1166174A Sterol compsns. from pulping soap
11/26/1997	CN1166173A Tetrahydropyridine-(or 4-hydroxypiperidine) Alkylazoles having an affinity for sigma and/or 5HTIA receptors
11/26/1997	CN1166171A N-substituted piperidinyl bicyclic benzoate derivatives
11/26/1997	CN1166170A Novel taxoids, preparation thereof, and pharmaceutical compsns. containing same
11/26/1997	CN1166169A Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
11/26/1997	CN1166167A Novel prostaglandin synthase inhibitors
11/26/1997	CN1165821A Annona lactone analogue and its use
11/26/1997	CN1165817A New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
11/26/1997	CN1165814A Amino benzene carbon amidine derivative and its use
11/26/1997	CN1165655A Method of treating conditions with estrogen agonists
11/26/1997	CN1165654A Combination therapy to treat osteoporosis-polyphosphonates or progesting and extrogen agonists
11/26/1997	CN1165653A Stable aqueous solubilizates of carotenoids and vitamins
11/26/1997	CN1165652A Meadow saffron alkaline pasting agent
11/26/1997	CN1165651A Use of (E)-1£4'-(2-alkylaminoethioxy) phenyl\|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
11/26/1997	CN1165650A 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease
11/26/1997	CN1165649A Method of increasing testostrone
11/26/1997	CN1165634A Method for prepn. of vitamin M functional foods
11/26/1997	CN1036521C Process for preparing ester of organic acid with alcohol derivatives of 19-norsteroids and their salts
11/26/1997	CN1036520C 1,4-diazepine derivative prepn. method
11/26/1997	CN1036501C Solid reagent for pencillin skin test and its prodn. method
11/25/1997	US5691423 Polysaccharide-bound nitric oxide-nucleophile adducts
11/25/1997	US5691387 Treatment of sickle cell anemia with nonionic surfactants
11/25/1997	US5691386 Triterpenoid compound for the treatment of diabetes
11/25/1997	US5691385 Growth promotion
11/25/1997	US5691384 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
11/25/1997	US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691380 Skin disorders
11/25/1997	US5691379 Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
11/25/1997	US5691378 Method for treating wrinkles using combinations of alpha hydroxyacids and/or alpha ketoacids
11/25/1997	US5691377 Use of N-methyl-aspartic acid for enhancing growth and altering body composition
11/25/1997	US5691375 Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
11/25/1997	US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997	US5691373 Nonpeptide endothelin antagonists I
11/25/1997	US5691372 Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
11/25/1997	US5691371 Antitumor and -carcinogenic agents; prodrugs bioreduced to release a cytotoxin, a mechlorethamine derivative; water soluble
11/25/1997	US5691370 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists
11/25/1997	US5691369 Cardiovascular disorders
11/25/1997	US5691368 Therapy for neurodegenerative disorders
11/25/1997	US5691366 Unsaturated nitro oxime formed by reaction of dinitrogen trioxide with diolefin ether, sulfide or amine to be used as vasodilators
11/25/1997	US5691365 Nicotinic receptor antagonists in the treatment of neuropharmacological disorders
11/25/1997	US5691364 Benzamidine derivatives and their use as anti-coagulants
11/25/1997	US5691361 1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow
11/25/1997	US5691359 Antiinflammatory agents
11/25/1997	US5691358 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/25/1997	US5691355 Syneristic mixture; therapy for breast cancer
11/25/1997	US5691354 Treating cardiovascular disorders
11/25/1997	US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds
11/25/1997	US5691352 Stable pharmaceutical composition of terfenadine and ibuprofen
11/25/1997	US5691350 Use of linomide for treatment of retrovirus infections specifically HIV infections
11/25/1997	US5691349 Quinclidine derivatives as squalene synthase inhibitors
11/25/1997	US5691348 Pyridyl imidazole derivatives and processes for the preparation thereof
11/25/1997	US5691347 Angiotensin ii inhibitors and vasoconstriction

1 ... 6720 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 ... 7860